The appeal of deploying an AI assistant for pharmaceutical knowledge management is obvious: a system that can answer questions like "what is the safety profile of compound X in patients over 70?" or "which of our products have label restrictions related to hepatic impairment?" would save substantial time across medical affairs, regulatory, and clinical development teams. The challenge is that generic AI assistants answer these questions based on public training data, which does not include your internal clinical data, your product-specific safety database, or your proprietary regulatory history.
The Internal Knowledge Graph as the Foundation
A portfolio-aware AI assistant must be grounded in an internal knowledge graph that captures the structured facts about your specific products. This graph includes: all approved indications and their supporting evidence, all label restrictions and contraindications with their regulatory basis, safety data from clinical trials and post-marketing surveillance, the status of ongoing development programmes, and cross-product relationships (shared mechanisms, shared patient populations, shared adverse event profiles). The knowledge graph is the authoritative source of facts; the language model is the interface that makes those facts accessible in natural language.
Query Decomposition and Multi-hop Retrieval
Complex queries about a drug portfolio often require multi-hop retrieval from the knowledge graph: a question about compounds suitable for a patient with both diabetes and renal impairment must retrieve the indication set for each compound, then apply the contraindication structure for each compound against the patient's conditions, then filter for compounds where no absolute contraindication applies. Modern RAG architectures support this multi-hop retrieval through iterative query-refine-retrieve loops, where each retrieval step informs the next query against the knowledge graph.
Access Control and Confidentiality
An internal AI assistant must enforce the same access control policies as the underlying knowledge graph. A medical affairs query may be permitted to access the full clinical evidence record for a compound; a commercial query may be restricted to approved label claims. The knowledge graph access layer must tag each assertion with the appropriate access level, and the AI assistant must enforce those tags in its retrieval queries and in the citations it provides. Building access control into the knowledge graph at the assertion level, rather than at the application level, ensures that it applies consistently across all consuming applications.
